Macrophage-targeted therapeutics for metabolic disease

KR Peterson, MA Cottam, AJ Kennedy… - Trends in pharmacological …, 2018 - cell.com
Macrophages are cells of the innate immune system that are resident in all tissues, including
metabolic organs such as the liver and adipose tissue (AT). Because of their phenotypic …

Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases

W He, N Kapate, CW Shields IV, S Mitragotri - Advanced drug delivery …, 2020 - Elsevier
Macrophages play a key role in defending against foreign pathogens, healing wounds, and
regulating tissue homeostasis. Driving this versatility is their phenotypic plasticity, which …

Biomimetic proteolipid vesicles for targeting inflamed tissues

R Molinaro, C Corbo, JO Martinez, F Taraballi… - Nature materials, 2016 - nature.com
A multitude of micro-and nanoparticles have been developed to improve the delivery of
systemically administered pharmaceuticals, which are subject to a number of biological …

[HTML][HTML] Targeting of hepatic macrophages by therapeutic nanoparticles

CI Colino, JM Lanao, C Gutierrez-Millan - Frontiers in immunology, 2020 - frontiersin.org
Hepatic macrophage populations include different types of cells with plastic properties that
can differentiate into diverse phenotypes to modulate their properties in response to different …

Efficient targeting of adipose tissue macrophages in obesity with polysaccharide nanocarriers

L Ma, TW Liu, MA Wallig, IT Dobrucki, LW Dobrucki… - ACS …, 2016 - ACS Publications
Obesity leads to an increased risk for type 2 diabetes, heart disease, stroke, and cancer. The
causal link between obesity and these pathologies has recently been identified as chronic …

Macrophage-targeted nanomedicine for chronic diseases immunotherapy

Y Song, Y Huang, F Zhou, J Ding, W Zhou - Chinese Chemical Letters, 2022 - Elsevier
Macrophage is the key innate immune effector in first-line defense against the pathogens,
and can be polarized into different phenotypes to regulate a variety of immunological …

Enhancing inflammation targeting using tunable leukocyte-based biomimetic nanoparticles

A Zinger, M Sushnitha, T Naoi, G Baudo, E De Rosa… - ACS …, 2021 - ACS Publications
Biomimetic nanoparticles aim to effectively emulate the behavior of either cells or exosomes.
Leukocyte-based biomimetic nanoparticles, for instance, incorporate cell membrane …

Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems

JC Kraft, JP Freeling, Z Wang, RJY Ho - Journal of pharmaceutical …, 2014 - Elsevier
Liposomes are spherical-enclosed membrane vesicles mainly constructed with lipids. Lipid
nanoparticles are loaded with therapeutics and may not contain an enclosed bilayer. The …

Drug delivery strategies to control macrophages for tissue repair and regeneration

R Garash, A Bajpai… - Experimental biology …, 2016 - journals.sagepub.com
Tissue repair and regeneration is a complex process. Our bodies have an excellent capacity
to regenerate damaged tissues in many situations. However, tissue healing is impaired in …

[HTML][HTML] Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals

V Bagalkot, MA Badgeley, T Kampfrath… - Journal of controlled …, 2015 - Elsevier
Macrophages are innate immune cells with great phenotypic plasticity, which allows them to
regulate an array of physiological processes such as host defense, tissue repair, and …